Creative Planning’s Biogen BIIB Stock Holding History

Creative Planning’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-400	Closed	-$3K	–	4354
2016 Q1	$3K	Sell	400 -600	-60%	-$158K	﹤0.01%	3785
2015 Q4	$1K	Buy	+1,000	New	+$287K	﹤0.01%	4180

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Creative Planning's BIIB Position: Q2 2026 in Review

Creative Planning increased its Biogen (BIIB) stake by 18% in Q2 2026, buying an estimated $4.09M and bringing the position to 138,613 shares worth $29.9M. The position accounts for 0.02% of the portfolio, ranked #364.

Creative Planning first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Creative Planning held 138,613 shares of Biogen worth $29.9M as of Q2 2026.
Creative Planning bought 21,377 Biogen shares in Q2 2026, an estimated $4.09M.
Biogen made up 0.02% of Creative Planning's portfolio in Q2 2026, its #364 holding.
Creative Planning first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.